News and Announcements
Leaf Resources Raises $3M & Secures Key Partnerships to Advance Malaysian Biorefinery
- Published December 19, 2017 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
KEY TAKEAWAYS:
- Leaf Resources Limited (ASX: LER) raised $3 million by placing 33,333,333 shares priced at $0.09.
- Leaf Malaysia signs a Letter of Intent (LOI) for provision of biomass
- Leaf Resources and Verdezyne sign collaboration agreement to develop EFB sugars for biobased chemicals
- A term sheet for a Malaysian biorefinery site was announced
- Leaf Resources signs an exclusive agency agreement with HB International
- Leaf Resources enters biodegradable packaging market leveraging Glycell strategy
- Leaf Resources secures another top 10 position in the 40 Hottest Emerging Companies in the Bioeconomy
- Presented at the 2017 WI Singapore Asia-Pacific Emerging Company Showcase
Leaf Resources is strongly positioned for both short and long-term success. Our strategy is clearly articulated and supported by numerous collaborative partnerships, industry recognition and technology advances. We have further consolidated our position within the bio-economy as we seek to rapidly enter the biodegradable packaging market and commercialise our first plant in Malaysia.
About Leaf Resources (ASX: LER)
Leaf Resources is an emerging renewable chemical company focused on commercialising the GlycellTM process; A disruptive technology that alters the economics of using biomass as a feedstock for the production of industrial sugars that can be used to produce biobased chemicals, bioplastics and other renewable products. Leaf Resources was voted #4 of the Hottest Small Companies in the Advanced Bio-Economy 2016/17 ABLC San Fran.
Company Updates
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
The Light Fantastic: Why Invion’s Photodynamic Therapy May Be Attracting Big Pharma’s Attention
Invion Limited is challenging the status quo in oncology with its Photosoft™ platform, a precision therapy that uses light-activated molecules to selectively target cancer cells. By transforming the body’s own immune response and addressing the high costs of current cancer treatments, Invion is positioning itself as a transformative player in the biotech sector. With clinical trials underway and strong institutional partnerships, the company is bridging the gap between scientific breakthrough and accessible, scalable patient care.
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship
From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.
Backed By Leading Investment Groups and Family Offices
